Evidence map›Paper›PMID 40351348›Full record

Trial reportDrug design, development and therapy2025

Comparison Between Low-Dose Esketamine and Dexmedetomidine on Postoperative Recovery Quality Among Patients Undergoing Humeral Trauma Surgery in Interscalene Brachial Plexus Block: A Randomized, Double-Blind, Controlled Trial.

Jiao Chen, Yu Qi, Jun Zhang, Bin Sun, Meng Zhang, Xiangdi Meng, Meiyan Zhou, Liwei Wang

Abstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in Drug design, development and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jiao Chen *The Xuzhou Clinical College of Xuzhou Medical University, Jiangsu, People's Republic of China.
Yu Qi *The Xuzhou Clinical College of Xuzhou Medical University, Jiangsu, People's Republic of China.ORCID 0000-0001-8029-2207
Jun Zhang *The Xuzhou Clinical College of Xuzhou Medical University, Jiangsu, People's Republic of China.
Bin SunThe Xuzhou Clinical College of Xuzhou Medical University, Jiangsu, People's Republic of China.
Meng ZhangDepartment of Anesthesiology, Xuzhou Central Hospital, Jiangsu, People's Republic of China.
Xiangdi MengDepartment of Anesthesiology, Xuzhou Central Hospital, Jiangsu, People's Republic of China.
Meiyan ZhouThe Xuzhou Clinical College of Xuzhou Medical University, Jiangsu, People's Republic of China.
Liwei WangThe Xuzhou Clinical College of Xuzhou Medical University, Jiangsu, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Patients with humeral fracture often suffer from post-traumatic neuropsychiatric sequelae, which can cause immense anxiety or fear and worsen recovery. In this report, we examined the effect of low-dose esketamine versus dexmedetomidine on postsurgical recovery among patients who underwent humerus surgery with interscalene brachial plexus block. Patients and Methods: In this prospective, randomized, controlled study, 141 patients aged 18 to 65 years who underwent humerus reduction and internal fixation were recruited. Patients were randomly assigned to two groups: esketamine (Group E: received 0.2 mg/kg (i.v.) esketamine administration, with subsequent continuous 0.15mg/kg/h infusion); dexmedetomidine (Group D: received 10-min 0.8µg/kg dexmedetomidine infusion, with 0.4ug/kg/h maintenance infusion). All infusions were terminated at closure of surgical incisions. Our major endpoint was the Quality of Recovery-40 (QoR-40) score on postoperative day 1 (POD-1). The secondary outcomes were QoR-40 POD-3, the intraoperative modified observer's assessment of alert/Sedation (MOAA/S) scores at 5 min (T1) and 10 min (T2) post i.v. administration, at operation initiation (T3), at 10 min interval (T4), 30 min interval (T5) post operation, and at the end of operation (T6), Numeric Rating Scale (NRS) at POD-1, additional postoperative analgesic usage and hospital stays. In addition, we analyzed safety indices, such as hemodynamic profile, postoperative nausea and vomiting, adverse events (AEs) involving the central nervous system. Results: The QoR-40 scores on POD-1 for Group E were substantially elevated relative to Group D. The T4 and T5 MOAA/S scores of Group D were lower relative to Group E. In comparison to Group E, Group D exhibited reduced T1 and T2 Mean arterial pressure (MAP) and T1-T6 Heart rate (HR). Lastly, we observed no marked alteration in other postsurgical AEs between the two patient cohorts. Conclusion: Continuous low-dose esketamine infusion seems safely and tolerably, it significantly improves the postoperative recovery quality among patients with ASA I or II receiving elective humeral trauma surgery.

Indexed as

Brachial Plexus BlockDexmedetomidineHumeral FracturesHumerusKetamineAcute Care SurgeryAdolescentAdultAgedDose-Response Relationship, DrugDouble-Blind MethodFemaleHumansMaleMiddle AgedPostoperative PainDexmedetomidineEsketamineKetaminedexmedetomidineesketamineHumeral trauma surgeryQoR-40quality of postoperative recovery

Identifiers

PMID40351348
PMCPMC12063633

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.